Critical issues concerning biocreative strategy in contemporary temporary skeletal anchorage device orthodontics: A narrative review

Author(s):  
Ki‐Ho Park ◽  
Jin‐Young Choi ◽  
Kyung A Kim ◽  
Su‐Jung Kim ◽  
Kyu‐Rhim Chung ◽  
...  
2019 ◽  
Vol 43 (2) ◽  
pp. 131-136 ◽  
Author(s):  
Un-Bong Baik ◽  
Junji Sugawara ◽  
Youn-Sic Chun ◽  
Suchita Mandair ◽  
Jae Hyun Park

Missing posterior teeth and posterior tooth extractions are commonly seen and needed within orthodontic practices. With the invention of temporary skeletal anchorage devices (TSADs), clinicians can now effectively close posterior tooth spaces. Various molar occlusions are discussed to help clinicians envision post-treatment occlusions after posterior teeth space closure using TSADs.


Life ◽  
2020 ◽  
Vol 10 (8) ◽  
pp. 146
Author(s):  
Caterina Monari ◽  
Valeria Gentile ◽  
Clarissa Camaioni ◽  
Giulia Marino ◽  
Nicola Coppola ◽  
...  

Background: The outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the related disease (COVID-19) has rapidly spread to a pandemic proportion, increasing the demands on health systems for the containment and management of COVID-19. Nowadays, one of the critical issues still to be pointed out regards COVID-19 treatment regimens and timing: which drug, in which phase, for how long? Methods: Our narrative review, developed using MEDLINE and EMBASE, summarizes the main evidences in favor or against the current proposed treatment regimens for COVID-19, with a particular focus on antiviral agents. Results: Although many agents have been proposed as possible treatment, to date, any of the potential drugs against SARS-CoV-2 has shown to be safe and effective for treating COVID-19. Despite the lack of definitive evidence, remdesivir remains the only antiviral with encouraging effects in hospitalized patients with COVID-19. Conclusions: In such a complex moment of global health emergency, it is hard to demand scientific evidence. Nevertheless, randomized clinical trials aiming to identify effective and safe drugs against SARS-CoV-2 infection are urgently needed in order to confirm or reject the currently available evidence.


Sign in / Sign up

Export Citation Format

Share Document